These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18510248)

  • 41. [Complement system and diabetic retinopathy].
    Zheng BQ; Zheng Z
    Zhonghua Yan Ke Za Zhi; 2013 Jul; 49(7):661-4. PubMed ID: 24257364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cytokines and their role in pathogenesis of diabetic retinopathy].
    Tret'iak EB; Syroedova ON; Neuhaus O; Andreeva AV; Antsiferov MB; Mkrtumian AM; Suchkov SV
    Vestn Oftalmol; 2010; 126(6):53-7. PubMed ID: 21395004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Ocular complications of diabetes mellitus--pathogenesis and risk factors of development].
    Matsui M
    Nihon Rinsho; 1991 Feb; 49 Suppl():281-6. PubMed ID: 1709706
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic potential of anti-oxidants and diabetic retinopathy.
    Kowluru RA; Kennedy A
    Expert Opin Investig Drugs; 2001 Sep; 10(9):1665-76. PubMed ID: 11772276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the management of diabetic retinopathy.
    Dulull N; Kwa F; Osman N; Rai U; Shaikh B; Thrimawithana TR
    Drug Discov Today; 2019 Aug; 24(8):1499-1509. PubMed ID: 30954684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinal Neurodegeneration in the Course of Diabetes-Pathogenesis and Clinical Perspective.
    Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Curr Neuropharmacol; 2016; 14(8):805-809. PubMed ID: 26915422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Emphasizing the early prevention and treatment for diabetic retinopathy].
    Xu X
    Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):9-11. PubMed ID: 18510234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular pathogenesis of diabetic retinopathy].
    Yamashita H
    Nihon Rinsho; 1997 Oct; 55 Suppl():960-5. PubMed ID: 9392225
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.
    Stem MS; Gardner TW
    Curr Med Chem; 2013; 20(26):3241-50. PubMed ID: 23745549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chinese herbal drugs for the treatment of diabetic retinopathy.
    Behl T; Kotwani A
    J Pharm Pharmacol; 2017 Mar; 69(3):223-235. PubMed ID: 28124440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Modern concepts of pathogenesis of diabetic retinopathy].
    Filippov VM; Petrachkov DV; Budzinskaya MV; Sidamonidze AL
    Vestn Oftalmol; 2021; 137(5. Vyp. 2):306-313. PubMed ID: 34669342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential new strategies to prevent the development of diabetic retinopathy.
    Mohr S
    Expert Opin Investig Drugs; 2004 Mar; 13(3):189-98. PubMed ID: 15013939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of aldosterone in the pathogenesis of diabetic retinopathy.
    Liu K; Zou H; Fan H; Hu H; Cheng Y; Liu J; Wu X; Chen B; You Z
    Front Endocrinol (Lausanne); 2023; 14():1163787. PubMed ID: 37113483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New insights into the pathogenesis of diabetic retinopathy--hormonal rather than metabolic factors are important.
    Chantelau E; Volaco A; Meyer-Schwickerath R
    Vasa; 2004 Nov; 33(4):205-10. PubMed ID: 15623194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring various novel diagnostic and therapeutic approaches in treating diabetic retinopathy.
    Sood A; Baishnab S; Gautam I; Choudhary P; Lang DK; Jaura RS; Singh TG
    Inflammopharmacology; 2023 Apr; 31(2):773-786. PubMed ID: 36745243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of diabetes mellitus and its complications. 1. Diabetic retinopathy].
    Hotta N
    Nihon Naika Gakkai Zasshi; 1996 Sep; 85(9):1464-8. PubMed ID: 8999091
    [No Abstract]   [Full Text] [Related]  

  • 58. Association of serum inflammatory markers and diabetic retinopathy: a review of literature.
    Gouliopoulos NS; Kalogeropoulos C; Lavaris A; Rouvas A; Asproudis I; Garmpi A; Damaskos C; Garmpis N; Kostakis A; Moschos MM
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7113-7128. PubMed ID: 30468452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diabetes mellitus and its complications in Japan. Pathogenesis and correspondence of diabetic retinopathy--approach from polyol metabolism].
    Hotta N; Sakamoto N
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1451-6. PubMed ID: 1761927
    [No Abstract]   [Full Text] [Related]  

  • 60. [New concepts on diabetic retinopathy: neural versus vascular damage].
    Serrarbassa PD; Dias AF; Vieira MF
    Arq Bras Oftalmol; 2008; 71(3):459-63. PubMed ID: 18641842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.